Micro guide catheters are used in complex
interventional procedures like neuroangiography and intravascular neurosurgery
to guide other devices into the brain and spinal vessels. Advancement in
catheter technologies has resulted in development of more flexible and
torqueable micro catheters with distal tip flexibility and steerability,
enabling surgeons to navigate tortuous vascular anatomy with ease.
The global Micro
Guide Catheters Market is estimated to be valued at US$ 227.91 Mn in 2023 and
is expected to exhibit a CAGR of 5.7% over the forecast period 2024 to 2031, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
Technological Advancement: One of the key trends driving growth in the Micro
Guide Catheters Market is ongoing technological innovation. Leading players are
developing novel micro catheters featuring advanced designs such as hydrophilic
coatings, improved steerability and trackability, and distal atraumatic tips
for safer access and navigation through tortuous paths without causing vessel
damage. Hydrophilic coatings in particular reduce friction during catheter
movement through vessels. Newer technologies are also enabling development of
micro catheters compatible with various imaging modalities like CT, MRI, and
angiography for enhanced guidance during procedures. Such technological
enhancement of products is expected to further increase market penetration over
the forecast period.
Segment
Analysis
The global micro guide catheters market is dominated by the neurovascular
segment. Neurovascular applications account for a prominent share in the market
due to the increasing prevalence of neurological disorders such as strokes,
brain aneurysms, and brain tumors. Micro guide catheters are widely used in
neurovascular procedures like carotid artery stenting, coiling of intracranial
aneurysms, and neurothrombectomies. The rising number of minimally invasive
neurosurgeries performed globally is a key factor boosting demand in this
segment.
Key Takeaways
The global micro guide catheters market is expected to witness high growth over
the forecast period of 2024 to 2031. Growing geriatric population more
susceptible to chronic diseases and rising preference for minimally invasive
surgeries are projected to drive the demand. Global
Micro Guide Catheters Market Size is estimated to be valued at US$
227.91 Mn in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast
period 2024 to 2031.
Regional analysis
North America currently dominates the global market and is expected to maintain
its leading position during the forecast period. This can be attributed to
advanced healthcare infrastructure, rising healthcare spending, growing
prevalence of cerebrovascular and cardiovascular diseases. According to the
American Heart Association, around 795,000 Americans suffer a stroke every
year, with someone having a stroke every 40 seconds. Favorable reimbursement
policies are also supporting the regional market growth.
Asia Pacific is anticipated to witness the fastest growth supported by growing
medical tourism, increasing healthcare spending, rising incidence of target
diseases. Countries such as China, India, Japan, and South Korea are expected
to drive the regional market.
Key players
Key players operating in the micro guide catheters market are Zealand Pharma
A/S, Eli Lilly and Company, Xeris Pharmaceuticals, Inc., Rezolute, Inc., Hanmi
Pharm.Co., Ltd., Fresenius Kabi AG, Eiger BioPharmaceuticals.,Crinetics
Pharmaceuticals, Inc., AmideBio,LLC, Jolly Healthcare, e5 Pharma,LLC, Merck
& Co.,Inc., Novo Nordisk A/S, Amphaster Pharmaceuticals,Inc., USV Private
Limited, Teva Pharmaceutical Industries Ltd.
Comments
Post a Comment